Peregrine's Selective Anti-VEGF Antibodies are as Effective as Avastin(R) in Preclinical Cancer Models According to Data Presented.

0 Comments | M2 Presswire, April, 2007

M2 PRESSWIRE-17 April 2007-Headline Maker: Peregrine's Selective Anti-VEGF Antibodies are as Effective as Avastin(R) in Preclinical Cancer Models According to Data Presented(C)1994-2007 M2 COMMUNICATIONS LTD RDATE:17042007 Market Gainer is quickly emerging as the one stop shop for international small-cap investors looking to stay a step ahead of the markets.

Activity on the NASDAQ market has brought this company to the attention of our research team. Peregrine Pharmaceuticals, Inc. (Nasdaq: PPHM), is responding to the attention of investors. Our goal is to create a community of international investors who consistently and effectively capitalize on the enormous gains the small-cap Canadian and American exchanges offer. Peregrine Pharmaceuticals, Inc....